IN VITRO ASSESSMENT OF METABOLIC DRUG-DRUG INTERACTION POTENTIAL OF APIXABAN THROUGH CYTOCHROME P450 PHENOTYPING, INHIBITION, AND INDUCTION STUDIES (vol 38, pg 448, 2010)

被引：1
|
作者：
Wang, L.
Zhang, D.
Raghavan, N.
Yao, M.
Ma, L.
Frost, C. E.
Maxwell, B. D.
Chen, S.
He, K.
Goosen, T. C.
Griffith, W. H.
Grossman, S. J.
机构：
来源：
DRUG METABOLISM AND DISPOSITION | 2010年 / 38卷 / 05期
关键词：
D O I：
10.1124/dmd.109.000019
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：887 / 887
页数：1
相关论文
共 50 条
  • [1] In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
    Wang, Lifei
    Zhang, Donglu
    Raghavan, Nirmala
    Yao, Ming
    Ma, Li
    Frost, Charles A.
    Maxwell, Brad D.
    Chen, Shiang-yuan
    He, Kan
    Goosen, Theunis C.
    Humphreys, W. Griffith
    Grossman, Scott J.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 448 - 458
  • [2] In vitro assessment of cytochrome P450 metabolic drug-drug interaction potential of ciclesonide
    Chu, V
    Zeng, ZP
    Pan, JM
    Wei, YYV
    Rao, ZS
    Chen, J
    King, SP
    DRUG METABOLISM REVIEWS, 2004, 36 : 276 - 276
  • [3] In Vitro Evaluation of Potential Drug-Drug Interactions with Ticagrelor: Cytochrome P450 Reaction Phenotyping, Inhibition, Induction, and Differential Kinetics
    Zhou, Diansong
    Andersson, Tommy B.
    Grimm, Scott W.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (04) : 703 - 710
  • [4] In vitro assessment of metabolic drug-drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P450 enzyme identification, inhibition, and induction studies
    Li, Yan
    Zhou, Diansong
    Ferguson, Stephen S.
    Dorff, Peter
    Simpson, Thomas R.
    Grimm, Scott W.
    XENOBIOTICA, 2010, 40 (11) : 721 - 729
  • [5] Current Cytochrome P450 Phenotyping Methods Applied to Metabolic Drug-Drug Interaction Prediction in Dogs
    Mills, Beth Miskimins
    Zaya, Matthew J.
    Walters, Rodney R.
    Feenstra, Kenneth L.
    White, Julie A.
    Gagne, Jason
    Locuson, Charles W.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 396 - 404
  • [6] In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes
    Chen, Nancy
    Cui, Donghui
    Wang, Qing
    Wen, Zhiming
    Finkelman, Richard D.
    Welty, Devin
    XENOBIOTICA, 2018, 48 (06) : 637 - 646
  • [7] Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
    Kamble, Shyam H.
    Sharma, Abhisheak
    King, Tamara I.
    Berthold, Erin C.
    Leon, Francisco
    Meyer, P. Katharina L.
    Kanumuri, Siva Rama Raju
    McMahon, Lance R.
    McCurdy, Christopher R.
    Avery, Bonnie A.
    TOXICOLOGY LETTERS, 2020, 319 : 148 - 154
  • [8] Molecular mechanisms of cytochrome P450 induction: Potential for drug-drug interactions
    Jana, Snehasis
    Paliwal, Jyoti
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (06) : 619 - 628
  • [9] Drug-Drug Interaction Potential of Marketed Oncology Drugs: In Vitro Assessment of Time-Dependent Cytochrome P450 Inhibition, Reactive Metabolite Formation and Drug-Drug Interaction Prediction
    Kenny, Jane R.
    Mukadam, Sophie
    Zhang, Chenghong
    Tay, Suzanne
    Collins, Carol
    Galetin, Aleksandra
    Khojasteh, S. Cyrus
    PHARMACEUTICAL RESEARCH, 2012, 29 (07) : 1960 - 1976
  • [10] Metabolic Drug-Drug Interaction Potential of Macrolactin A and 7-O-Succinyl Macrolactin A Assessed by Evaluating Cytochrome P450 Inhibition and Induction and UDP-Glucuronosyltransferase Inhibition In Vitro
    Bae, Soo Hyeon
    Kwon, Min Jo
    Park, Jung Bae
    Kim, Doyun
    Kim, Dong-Hee
    Kang, Jae-Seon
    Kim, Chun-Gyu
    Oh, Euichaul
    Bae, Soo Kyung
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5036 - 5046
12345